Comparison of the Effect of the GABAB Receptor Agonist, Baclofen, and the Positive Allosteric Modulator of the GABAB Receptor, GS39783, on Alcohol Self-Administration in 3 Different Lines of Alcohol-Preferring Rats

Alcoholism: Clinical and Experimental Research

Volumn 36, Issue 10, 2012, Pages 1748-1766

  Maccioni, Paola ^a   Zaru, Alessandro ^a   Loi, Barbara ^a   Lobina, Carla ^a   Carai, Mauro A M ^a   Gessa, Gian Luigi ^a   Capra, Alessandro ^b   Mugnaini, Claudia ^c   Pasquini, Serena ^c   Corelli, Federico ^c   Hyytiä, Petri ^d   Lumeng, Lawrence ^e   Colombo, Giancarlo ^a  

^a CNR   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY OF HELSINKI   (Finland)

^e INDIANA UNIVERSITY   (United States)

Author keywords

Alcohol preferring A rats; Alcohol preferring P rats; Alcohol preferring sP rats; GABAB receptor agonist baclofen; Operant oral alcohol self administration; Positive allosteric modulator of the GABAB Receptor GS39783; Reinforcing and motivational properties of alcohol

Indexed keywords

ALCOHOL; BACLOFEN; N,N' DICYCLOPENTYL 2 METHYLTHIO 5 NITRO 4,6 PYRIMIDINEDIAMINE;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALCOHOL DRINKING; ALLOSTERIC REGULATION; ANIMALS; BACLOFEN; CYCLOPENTANES; ETHANOL; GABA MODULATORS; GABA-B RECEPTOR AGONISTS; MALE; PYRIMIDINES; RATS; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; SPECIES SPECIFICITY;

RATTUS;

EID: 84867022253     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2012.01782.x     Document Type: Article

References (96)

1. Addolorato G, Caputo F, Capristo E, Colombo G, Gessa GL, Gasbarrini G (2000) Ability of baclofen in reducing alcohol craving and intake: II-Preliminary clinical evidence. Alcohol Clin Exp Res 24:67-71.
2. Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L, Agabio R, Colombo G, Gessa GL, Gasbarrini G (2002a) Baclofen efficacy in reducing alcohol craving and intake-a preliminary double-blind randomised controlled study. Alcohol Alcohol 37:504-508.
3. Addolorato G, Caputo F, Capristo E, Janiri L, Bernardi M, Agabio R, Colombo G, Gessa GL, Gasbarrini G (2002b) Rapid suppression of alcohol withdrawal syndrome by baclofen. Am J Med 112:226-229.
4. Addolorato G, Leggio L (2010) Safety and efficacy of baclofen in the treatment of alcohol-dependent patients. Curr Pharm Des 16:2113-2117.
5. Addolorato G, Leggio L, Abenavoli L, Agabio R, Caputo F, Capristo E, Colombo G, Gessa GL, Gasbarrini G (2006) Baclofen in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus diazepam. Am J Med 119:276.e13-276.e18.
6. Addolorato G, Leggio L, Abenavoli L, DeLorenzi G, Parente A, Caputo F, Janiri L, Capristo E, Rapaccini GL, Gasbarrini G (2003) Suppression of alcohol delirium tremens by baclofen administration: a case report. Clin Neuropharmacol 26:258-262.
7. Addolorato G, Leggio L, Ferrulli A, Cardone S, Bedogni G, Caputo F, Gasbarrini G, Landolfi R, Baclofen Study Group (2011) Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol Alcohol 46:312-317.
8. Addolorato G, Leggio L, Ferrulli A, Cardone S, Vonghia L, Mirijello A, Abenavoli L, D'Angelo C, Caputo F, Zambon A, Haber PS, Gasbarrini G (2007) Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 370:1915-1922.
9. B receptor system. Recent Pat CNS Drug Discov.
10. Agabio R, Marras P, Addolorato G, Carpiniello B, Gessa GL (2007) Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient: a case report. J Clin Psychopharmacol 27:319-320.
11. Ameisen O (2005) Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician. Alcohol Alcohol 40:147-150.
12. Ameisen O, de Beaurepaire R (2010) Suppression de la dépendance à l'alcool et de la consommation d'alcool par le baclofène à haute dose: un essai en ouvert [Suppression of alcohol dependence using high-dose baclofen: an observational study]. Ann Med Psychol 168:159-162.
13. Anstrom KK, Cromwell HC, Markowski T, Woodward DJ (2003) Effect of baclofen on alcohol and sucrose self-administration in rats. Alcohol Clin Exp Res 27:900-908.
14. Arias C, Mlewski EC, Molina JC, Spear NE (2009) Naloxone and baclofen attenuate ethanol's locomotor-activating effects in preweanling Sprague-Dawley rats. Behav Neurosci 123:172-180.
15. Babor TF, Hofmann M, DelBoca FK, Hesselbrock V, Meyer RE, Dolinsky ZS, Rounsaville B (1992) Types of alcoholics, I, evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry 49:599-608.
16. Bechtholt AJ, Cunningham CL (2005) Ethanol-induced conditioned place preference is expressed through a ventral tegmental area dependent mechanism. Behav Neurosci 119:213-223.
17. Bell RL, Rodd ZA, Lumeng L, Murphy JM, McBride WJ (2006) The alcohol-preferring P rat and animal models of excessive alcohol drinking. Addict Biol 11:270-288.
18. B receptor agonists reduce operant ethanol self-administration and enhance ethanol sedation in C57BL/6J mice. Psychopharmacology 174:358-366.
19. B receptor modulation of ethanol-stimulated activity in mice. Neuroscience 115:185-200.
20. Brebner K, Phelan R, Roberts DCS (2000a) Effect of baclofen on cocaine self-administration in rats reinforced under fixed ratio 1 and progressive ratio schedules. Psychopharmacology 148:314-321.
21. Brebner K, Phelan R, Roberts DC (2000b) Intra-VTA baclofen attenuates cocaine self-administration on a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav 66:857-862.
22. Bucknam W (2007) Suppression of symptoms of alcohol dependence and craving using high dose baclofen. Alcohol Alcohol 42:158-160.
23. Chester JA, Cunningham CL (1999) Baclofen alters ethanol-stimulated activity but not conditioned place preference or taste aversion in mice. Pharmacol Biochem Behav 63:325-331.
24. Cloninger CR (1987) Neurogenetic adaptive mechanisms in alcoholism. Science 236:410-416.
25. Colombo G, Agabio R, Carai MAM, Lobina C, Pani M, Reali R, Addolorato G, Gessa GL (2000) Ability of baclofen in reducing alcohol intake and withdrawal severity: I-Preclinical evidence. Alcohol Clin Exp Res 24:58-66.
26. Colombo G, Lobina C, Carai MAM, Gessa GL (2006a) Phenotypic characterization of genetically selected Sardinian alcohol-preferring (sP) and -non preferring (sNP) rats. Addict Biol 11:324-338.
27. B receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats. Alcohol Alcohol 37:499-503.
28. Colombo G, Serra S, Brunetti G, Vacca G, Carai MAM, Gessa GL (2003a) Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats. Drug Alcohol Depend 70:105-108.
29. Colombo G, Serra S, Vacca G, Carai MAM, Gessa GL (2006b) Baclofen-induced suppression of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats exposed to different alcohol concentrations. Eur J Pharmacol 550:123-126.
30. Colombo G, Serra S, Vacca G, Gessa GL, Carai MAM (2004) Suppression by baclofen of the stimulation of alcohol intake induced by morphine and WIN 55, 212-2 in alcohol-preferring rats. Eur J Pharmacol 492:189-193.
31. Colombo G, Vacca G, Serra S, Brunetti G, Carai MAM, Gessa GL (2003b) Baclofen suppresses motivation to consume alcohol in rats. Psychopharmacology 167:221-224.
32. B receptor-positive modulator GS39783 (N, N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4, 6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. J Pharmacol Exp Ther 310:952-963.
33. B agonist baclofen in rats. Alcohol Clin Exp Res 30:812-818.
34. Daoust M, Saligaut C, Lhuintre JP, Moore N, Flipo JL, Boismare F (1987) GABA transmission, but not benzodiazepine receptor stimulation, modulates ethanol intake by rats. Alcohol 4:469-472.
35. Dean RL, Eyerman D, Todtenkopf MS, Turncliff RZ, Bidlack JM, Deaver DR (2011) Effects of oral loperamide on efficacy of naltrexone, baclofen and AM-251 in blocking ethanol self-administration in rats. Pharmacol Biochem Behav 100:530-537.
36. Epstein EE, Kahler CW, McCrady BS, Lewis KD, Lewis S (1995) An empirical classification of drinking patterns among alcoholics: binge, episodic, sporadic, and steady. Addict Behav 20:23-41.
37. File SE, Zharkovsky A, Gulati K (1991) Effects of baclofen and nitrendipine on ethanol withdrawal responses in the rat. Neuropharmacology 30:183-190.
38. Files FJ, Denning CE, Hyytïa P, Kiianmaa K, Samson HH (1997) Ethanol-reinforced responding by AA and ANA rats following the sucrose-substitution initiation procedure. Alcohol Clin Exp Res 21:749-753.
39. B receptor agents on cocaine priming, discrete contextual cue and food induced relapses. Eur J Pharmacol 571:166-173.
40. B receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination. Eur J Pharmacol 574:148-157.
41. Flannery BA, Garbutt JC, Cody MW, Renn W, Grace K, Osborne M, Crosby K, Morreale M, Trivette A (2004) Baclofen for alcohol dependence: a preliminary open-label study. Alcohol Clin Exp Res 28:1517-1523.
42. B receptor ligands. Adv Pharmacol 58:19-62.
43. Garbutt JC, Kampov-Polevoy AB, Gallop R, Kalka-Juhl L, Flannery BA (2010) Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial. Alcohol Clin Exp Res 34:1849-1857.
44. Halbout B, Quarta D, Valerio E, Heidbreder CA, Hutcheson DM (2011) The GABA-B positive modulator GS39783 decreases psychostimulant conditioned-reinforcement and conditioned-reward. Addict Biol 16:416-427.
45. B, receptor agonist. Alcohol Clin Exp Res 33:108-120.
46. Janak PH, Gill TM (2003) Comparison of the effects of allopregnanolone with direct GABAergic agonists on ethanol self-administration with and without concurrently available sucrose. Alcohol 30:1-7.
47. Johnson BA (2010) Medication treatment of different types of alcoholism. Am J Psychiatry 167:630-639.
48. Johnson BA, Roache JD, Javors MA, DiClemente CC, Cloninger CR, Prihoda TJ, Bordnick PS, Ait-Daoud N, Hensler J (2000) Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial. J Am Med Assoc 284:963-971.
49. Knapp DJ, Overstreet DH, Breese GR (2007) Baclofen blocks expression and sensitization of anxiety-like behavior in an animal model of repeated stress and ethanol withdrawal. Alcohol Clin Exp Res 31:582-595.
50. Kranzler HR, Armeli S, Tennen H, Covault J, Feinn R, Arias AJ, Pettinati H, Oncken C (2011) A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age and 5-hydroxytryptamine transporter-linked promoter region genotype. J Clin Psychopharmacol 31:22-30.
51. Leite-Morris KA, Kerestes HB, Colombo G (2009) Intra-ventral tegmental area injection of the GABA B receptor positive allosteric modulator GS39783 inhibits ethanol seeking behavior in rats. Alcohol Clin Exp Res 33:226A.
52. Leite-Morris KA, Misch ES, Czachowski CL (2008) Intra-VTA activation of GABA(B) receptors modulates accumbal dopamine during ethanol seeking behavior. Alcohol Clin Exp Res 32:276A.
53. Lesch OM, Walter H (1996) Subtypes of alcoholism and their role in therapy. Alcohol Alcohol 31(Suppl 1):63-67.
54. B receptor-positive modulation decreases selective molecular and behavioral effects of cocaine. Neuropsychopharmacology 32:388-398.
55. B receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats. Neuropharmacology 50:632-639.
56. Maccioni P, Bienkowski P, Carai MAM, Gessa GL, Colombo G (2008a) Baclofen attenuates cue-induced reinstatement of alcohol-seeking behavior in Sardinian alcohol-preferring (sP) rats. Drug Alcohol Depend 95:284-287.
57. B receptor, BHF177, in alcohol-preferring rats. Alcohol Clin Exp Res 33:1749-1756.
58. B receptor in alcohol seeking and drinking behavior. Alcohol 43:555-558.
59. B receptor direct agonist, baclofen. Alcohol Clin Exp Res 32:1558-1564.
60. B receptor, GS39783, of alcohol self-administration in Sardinian alcohol-preferring rats exposed to the "sipper" procedure. Front Psychiatry 1:20.
61. B receptor, GS39783, on alcohol self-administration in alcohol-preferring rats. Psychopharmacology 193:171-178.
62. Maccioni P, Serra S, Vacca G, Orrù A, Pes D, Agabio R, Addolorato G, Carai MAM, Gessa GL, Colombo G (2005) Baclofen-induced reduction of alcohol reinforcement in alcohol-preferring rats. Alcohol 36:161-168.
63. B receptor, rac-BHFF, suppresses alcohol self-administration. Drug Alcohol Depend 109:96-103.
64. B receptors. Br J Pharmacol 154:797-811.
65. Markou A, Weiss F, Gold LH, Caine SB, Schulteis G, Koob GF (1993) Animal models of drug craving. Psychopharmacology 112:163-182.
66. B receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacology 29:1050-1062.
67. B receptor-positive modulation-induced blockade of the rewarding properties of nicotine is associated with a reduction in nucleus accumbens ΔFosB accumulation. J Pharmacol Exp Ther 321:172-177.
68. Moore EM, Boehm SL (2009) Site-specific microinjection of baclofen into the anterior ventral tegmental area reduces binge-like ethanol intake in male C57BL/6J mice. Behav Neurosci 123:555-563.
69. Muzyk AJ, Rivelli SK, Gagliardi JP (2012) Defining the role of baclofen for the treatment of alcohol dependence: a systematic review of the evidence. CNS Drugs 26:69-78.
70. B receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats. Eur J Pharmacol 525:105-111.
71. B receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats. J Pharmacol Exp Ther 326:306-314.
72. Perfumi M, Santoni M, Ciccocioppo R, Massi M (2002) Blockade of γ-aminobutyric acid receptors does not modify the inhibition of ethanol intake induced by Hypericum perforatum in rats. Alcohol Alcohol 37:540-546.
73. Petry NM (1997) Benzodiazepine-GABA modulation of concurrent ethanol and sucrose reinforcement in the rat. Exp Clin Psychopharmacol 5:183-194.
74. Pettinati HM (1996) Use of serotonin selective pharmacotherapy in the treatment of alcohol dependence. Alcohol Clin Exp Res 20:23A-29A.
75. Quintanilla ME, Perez E, Tampier L (2008) Baclofen reduces ethanol intake in high-alcohol-drinking University of Chile bibulous rats. Addict Biol 13:326-336.
76. Richardson NR, Roberts DC (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66:1-11.
77. Roberts DCS, Andrews MM (1997) Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure. Psychopharmacology 131:271-277.
78. Roberts DCS, Andrews MM, Vickers GJ (1996) Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacology 15:417-423.
79. Roman E, Stewart RB, Bertholomey ML, Jensen ML, Colombo G, Hyytiä P, Badia-Elder NE, Grahame NJ, Li T-K, Lumeng L (2012) Behavioral profiling of multiple pairs of rats selectively bred for high and low alcohol intake using the MCSF test. Addict Biol 17:33-46.
80. Rubio G, Ponce G, Rodriguez-Jimenez R, Jimenez-Arriero MA, Hoenicka J, Palomo T (2005) Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone? Alcohol Alcohol 40:227-233.
81. Samson HH, Files FJ, Denning C, Marvin S (1998) Comparison of alcohol-preferring and nonpreferring selectively bred rat lines. I. Ethanol initiation and limited access operant self-administration. Alcohol Clin Exp Res 22:2133-2146.
82. B receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat. Neuropsychopharmacology 30:2065-2072.
83. B agonist baclofen on the temporal and structural characteristics of ethanol intake. Alcohol 17:231-240.
84. Smith BR, Robidoux J, Amit Z (1992) GABAergic involvement in the acquisition of voluntary ethanol intake in laboratory rats. Alcohol Alcohol 27:227-231.
85. B receptor on cocaine self-administration in rats. Psychopharmacology 173:105-111.
86. Sommer W, Hyytiä P, Kiianmaa K (2006) The alcohol-preferring AA and alcohol-avoiding ANA rats: neurobiology of the regulation of alcohol drinking. Addict Biol 11:289-309.
87. Spanagel R, Kiefer F (2008) Drugs for relapse prevention of alcoholism: ten years of progress. Trends Pharmacol Sci 29:109-115.
88. Tanchuck MA, Yoneyama N, Ford MM, Fretwell AM, Finn DA (2011) Assessment of GABA-B, metabotropic glutamate, and opioid receptor involvement in an animal model of binge drinking. Alcohol 45:33-44.
89. B receptors in addiction and its treatment. Adv Pharmacol 58:373-396.
90. Urwyler S (2011) Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives. Pharmacol Rev 63:59-126.
91. Urwyler S, Pozza MF, Lingenhoehl K, Mosbacher J, Lampert C, Froestl W, Koller M, Kaupmann K (2003) N, N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4, 6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function. J Pharmacol Exp Ther 307:322-330.
92. Vacca G, Serra S, Brunetti G, Carai MAM, Samson HH, Gessa GL, Colombo G (2002) Operant self-administration of ethanol in Sardinian alcohol-preferring rats. Alcohol Clin Exp Res 26:1678-1685.
93. B receptors in reward processes. Adv Pharmacol 58:315-371.
94. B receptor positive allosteric modulators inhibit the expression of previously established methamphetamine-induced conditioned place preference. Behav Brain Res 216:419-423.
95. Walker BM, Koob GF (2007) The γ-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats. Alcohol Clin Exp Res 31:11-18.
96. B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice. Br J Pharmacol 163:1034-1047.